IQ EQ FUND MANAGEMENT IRELAND Ltd Sells 225 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

IQ EQ FUND MANAGEMENT IRELAND Ltd lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 13.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 1,456 shares of the medical equipment provider’s stock after selling 225 shares during the quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd’s holdings in Intuitive Surgical were worth $760,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. M.E. Allison & CO. Inc. purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the 4th quarter valued at $82,517,000. Sycomore Asset Management grew its position in Intuitive Surgical by 27.4% in the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after acquiring an additional 4,079 shares during the last quarter. Exome Asset Management LLC increased its stake in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. lifted its position in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $491.84 on Friday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The stock has a market cap of $175.18 billion, a PE ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The firm has a fifty day moving average price of $556.28 and a 200 day moving average price of $532.34.

Analysts Set New Price Targets

Several equities research analysts have issued reports on ISRG shares. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating for the company in a research report on Tuesday, March 18th. Citigroup lifted their price target on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Leerink Partners raised their target price on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, Barclays upped their price target on Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $611.86.

Insider Activity

In other news, Director Amal M. Johnson sold 4,635 shares of the business’s stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the sale, the director now directly owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 33,754 shares of company stock valued at $17,691,621 in the last quarter. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.